Finally, since HCs did not undergo other tests typically used to monitor disease activity in SLE, we couldn’t directly compare biomarker capabilities with commonly used indicators like C3, C4, and anti dsDNA. The gene discussed is C4A; the disease is systemic lupus erythematosus.